Huang Zhuoying, Wu Ye, Gao Mengxian, Wang Nan, Ma Zhonghui, Zhang Suyi, Yang Minyi, Wang Xinyu, Zhao Danni, Wen Zexuan, Zhou Wenyong, Zheng Bo, Tian Jie, Wang Weibing
Department of Epidemiology, School of Public Health, Fudan University, Shanghai, China.
Institute of Immunization, Shanghai Municipal Center of Disease Control and Prevention, Shanghai, China.
Hum Vaccin Immunother. 2025 Dec;21(1):2541496. doi: 10.1080/21645515.2025.2541496. Epub 2025 Aug 1.
The COVID-19 epidemic has significantly disrupted routine childhood immunization programs. This study assesses the impact of different COVID-19 prevalence phases on immunization coverage and timeliness in Shanghai, China. We employed a retrospective cohort design, encompassing children born between September 1, 2018, and August 30, 2023. Children were categorized into three COVID-19 phases based on their expected vaccination dates: baseline period, epidemic period, and pre/post-epidemic period. Kaplan-Meier estimators were utilized to ascertain the cumulative vaccination probabilities, with differences tested using the log-rank method. A multivariate Cox proportional hazards model was conducted to assess the impact of COVID-19 phases on vaccination timeliness. Vaccination timeliness significantly declined when the vaccination window coincided with an epidemic period, particularly for older children and during heightened epidemic activity. The probability of timely vaccination at 2 months was 0.89 (95% CI: 0.86-0.92) in the baseline period and 0.53 (95% CI: 0.51-0.55) in the epidemic period, compared to the pre/post-epidemic period. At 3 months, the probability of timely vaccination decreased 12% (HR = 0.88, 95% CI 0.86-0.90) and 49% (HR = 0.51, 95% CI 0.49-0.53), respectively. Similarly, for vaccinations scheduled at 4 months, the probabilities of timely vaccination were 0.87 (95% CI 0.85-0.89) and 0.49 (95% CI 0.47-0.51) times. At 5 months, the probabilities declined 9% (HR = 0.91, 95% CI 0.87-0.94) and 57% (HR = 0.43, 95% CI 0.40-0.46), correspondingly. Our study assessed the notable decline of vaccination timeliness during epidemic periods, highlighting the need for targeted strategies to mitigate disruptions in routine childhood immunization services.
新冠疫情严重扰乱了儿童常规免疫规划。本研究评估了中国上海不同新冠流行阶段对免疫接种覆盖率和及时性的影响。我们采用回顾性队列设计,纳入2018年9月1日至2023年8月30日出生的儿童。根据预期接种日期,将儿童分为三个新冠阶段:基线期、流行期和流行前/后时期。使用Kaplan-Meier估计量确定累积接种概率,并采用对数秩检验差异。进行多变量Cox比例风险模型评估新冠阶段对疫苗接种及时性的影响。当接种窗口与流行期重合时,疫苗接种及时性显著下降,尤其是对大龄儿童以及在疫情活动加剧期间。与流行前/后时期相比,2月龄时及时接种的概率在基线期为0.89(95%置信区间:0.86 - 0.92),在流行期为0.53(95%置信区间:0.51 - 0.55)。3月龄时,及时接种的概率分别下降了12%(风险比 = 0.88,95%置信区间0.86 - 0.90)和49%(风险比 = 0.51,95%置信区间0.49 - 0.53)。同样,对于4月龄安排的接种,及时接种的概率分别为0.87(95%置信区间0.85 - 0.89)和0.49(95%置信区间0.47 - 0.51)倍。5月龄时,概率相应下降了9%(风险比 = 0.91,95%置信区间0.87 - 0.94)和57%(风险比 = 0.43,95%置信区间0.40 - 0.46)。我们的研究评估了流行期间疫苗接种及时性的显著下降,强调需要有针对性的策略来减轻儿童常规免疫服务的中断。